MONTREAL, April 7, 2025 /CNW/ - Sylvain Chrétien, CEO and cofounder of Canadian biotech firm Synucure Therapeutics, is proud to announce a strategic financial partnership with the government of Québec, through its agent Investissement Québec. Under this agreement, the government of Québec is injecting 50% of funding, or $1.4 million, via the Impulsion PME program, becoming a shareholder in the business. The other half of the funding, $1.4 million, is provided by private investors.
Read more at newswire.caThis article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
/Cisco%20Systems%2C%20Inc_%20HQ-by%20Sundry%20Photography%20via%20iStock.jpg)
/Intel%20Corp_%20logo%20on%20mobile%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)